SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : IDPH--Positive preliminary results for pivotal trial of ID
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: I. Luttichuys who wrote (232)12/13/1996 2:36:00 PM
From: Roudy   of 1762
 
Hi Bennett, Newsrelease over the Reuters wire; Smith Kline Beecham adds to position in IDEC. They now own over 2000000 shares equating to a 11.3% stake in IDEC. Over the period of Dec 2 - 4 they purchased an additional 390,000 shares. Now you would think with institutional buying (especially someone in the know) like this, we would see more upward excitment in the stock. Personally, I would like to see the stock move up short term so I could unload some options I own. Didn't get the movement I expected from the ASH conference and Phase III press releases. However, as Brad has stated there could be some nice net dipping coming up over the next three to four months while the Biologics License Application is being prepared and submitted to the FDA. I'm impressed with how you keep up with investing and attending Med school. You must be one sharp cookie. Keep up the good work and I'll see you down the thread. Don
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News